tetano
Editor, Senior Moderator
Kidney Int
. 2021 Apr 20;S0085-2538(21)00391-4.
doi: 10.1016/j.kint.2021.04.007. Online ahead of print.
Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
T Alp Ikizler[SUP] 1 [/SUP], P Toby Coates[SUP] 2 [/SUP], Brad H Rovin[SUP] 3 [/SUP], Pierre Ronco[SUP] 4 [/SUP]
Affiliations
Abstract
In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest that there is durability of immune response after COVID-19 infection. Although immune response to the first dose of vaccine is less in infection-na?ve patients than healthy individuals in both groups, after the second vaccine dose a significant portion of patients receiving maintenance dialysis develop robust antibody titers, whereas kidney transplant recipients show a less-strong immune response.
. 2021 Apr 20;S0085-2538(21)00391-4.
doi: 10.1016/j.kint.2021.04.007. Online ahead of print.
Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
T Alp Ikizler[SUP] 1 [/SUP], P Toby Coates[SUP] 2 [/SUP], Brad H Rovin[SUP] 3 [/SUP], Pierre Ronco[SUP] 4 [/SUP]
Affiliations
- PMID: 33931226
- DOI: 10.1016/j.kint.2021.04.007
Abstract
In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest that there is durability of immune response after COVID-19 infection. Although immune response to the first dose of vaccine is less in infection-na?ve patients than healthy individuals in both groups, after the second vaccine dose a significant portion of patients receiving maintenance dialysis develop robust antibody titers, whereas kidney transplant recipients show a less-strong immune response.